Related Experiment Video
Updated: Aug 15, 2026
05:00
Short-Duration Hypothermia Induction in Rats using Models for Studies examining Clinical Relevance and Mechanisms
Published on: March 3, 2021
Therapeutic hypothermia: from lab to NICU
Alistair Jan Gunn1, Malcolm Battin, Peter D Gluckman
1University of Auckland, Auckland, New Zealand. aj.gunn@auckland.ac.nz
Journal of Perinatal Medicine
|October 7, 2005
Summary
Therapeutic hypothermia shows promise for newborns with perinatal asphyxia. Cooling initiated within 6 hours of reperfusion improves survival and is generally safe.
Area of Science:
- Neuroscience
- Neonatalogy
- Therapeutic Hypothermia
Background:
- Perinatal asphyxia can lead to delayed neuronal loss via complex biochemical cascades.
- Understanding these phases, including latent and secondary injury phases, is crucial for neuroprotection.
- Early studies on cerebral hypothermia had limited and contradictory results.
Purpose of the Study:
- To explore the therapeutic role of cerebral hypothermia in perinatal asphyxia.
- To understand how timing, duration, and depth of cooling influence neuroprotection.
- To evaluate the safety and efficacy of prolonged cerebral hypothermia.
Main Methods:
- Review of experimental parameters for effective hypothermic neuroprotection.
- Analysis of findings from adult and perinatal species studies.
- Inclusion of results from a large multicenter randomized trial on head cooling for neonatal encephalopathy.
Main Results:
- Moderate cerebral hypothermia, initiated 1-6 hours post-reperfusion, offers potent neuroprotection.
- Prolonged cerebral hypothermia is generally safe in intensive care settings.
- Evidence suggests improved intact survival up to 18 months of age.
Conclusions:
- Cerebral hypothermia is a viable therapeutic strategy for perinatal asphyxia.
- Optimizing cooling parameters enhances neuroprotective effects.
- Further research, including whole-body cooling studies, is ongoing.
